The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis  by Corsa, Callie A.S. et al.
ArticleThe Action of Discoidin Domain Receptor 2 in Basal
Tumor Cells and Stromal Cancer-Associated
Fibroblasts Is Critical for Breast Cancer MetastasisGraphical AbstractHighlightsd DDR2 activity in both tumor and stromal cells is critical for
breast cancer metastasis
d DDR2 regulates collective invasion/migration of basal K14+
breast tumor cells
d In CAFs, DDR2 regulates tumor ECMproduction and collagen
fiber remodeling
d In CAFs, DDR2 enhances tumor collective invasion/migrationCorsa et al., 2016, Cell Reports 15, 2510–2523
June 14, 2016 ª 2016 The Author(s)
http://dx.doi.org/10.1016/j.celrep.2016.05.033Authors
Callie A.S. Corsa, Audrey Brenot,
Whitney R. Grither, ..., Kevin W. Eliceiri,
Patricia J. Keely, Gregory D. Longmore
Correspondence
glongmore@wustl.edu
In Brief
Using an in vivo genetic approach, Corsa
et al. identify the actions of DDR2, a
distinctive receptor tyrosine kinase
activated by fibrillar collagens, in breast
cancer metastasis. DDR2 functions in
both tumor and stromal cells of primary
tumors, affecting metastasis but not
tumor growth.
Cell Reports
ArticleThe Action of Discoidin Domain Receptor 2
in Basal Tumor Cells and Stromal Cancer-Associated
Fibroblasts Is Critical for Breast Cancer Metastasis
Callie A.S. Corsa,1,2,3 Audrey Brenot,1,3 Whitney R. Grither,1,3,4 Samantha Van Hove,1,2,3 Andrew J. Loza,1,3,5
Kun Zhang,1,3 Suzanne M. Ponik,6 Yuming Liu,7 David G. DeNardo,1,3 Kevin W. Eliceiri,7 Patricia J. Keely,6,7
and Gregory D. Longmore1,2,3,*
1ICCE Institute, Washington University, St. Louis, MO 63110, USA
2Department of Cell Biology and Physiology
3Department of Medicine
4Department of Biochemistry
5Department of Computational and Molecular Biophysics
Washington University, St. Louis, MO 63110, USA
6Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA
7Laboratory for Optical and Computational Imaging, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA
*Correspondence: glongmore@wustl.edu
http://dx.doi.org/10.1016/j.celrep.2016.05.033SUMMARY
High levels of collagen deposition in human and
mouse breast tumors are associated with poor
outcome due to increased local invasion and distant
metastases. Using a genetic approach, we show
that, in mice, the action of the fibrillar collagen recep-
tor discoidin domain receptor 2 (DDR2) in both tumor
and tumor-stromal cells is critical for breast cancer
metastasis yet does not affect primary tumor growth.
In tumor cells, DDR2 in basal epithelial cells regulates
the collective invasion of tumor organoids. In stromal
cancer-associated fibroblasts (CAFs), DDR2 is crit-
ical for extracellular matrix production and the orga-
nization of collagen fibers. The action of DDR2 in
CAFs also enhances tumor cell collective invasion
through a pathway distinct from the tumor-cell-
intrinsic function of DDR2. This work identifies
DDR2 as a potential therapeutic target that controls
breast cancer metastases through its action in both
tumor cells and tumor-stromal cells at the primary
tumor site.
INTRODUCTION
Breast cancer is the second leading cause of cancer-related
deaths in women, and more than 90% of mortality is due to met-
astatic disease. The majority of breast cancers originate in the
epithelial cells lining the mammary ducts as a result of hereditary
or acquired genetic mutations that largely affect tumor cell
growth and survival (Vargo-Gogola and Rosen, 2007). However,
tumor development and progression is also accompanied by
changes in the surrounding cellular, chemical, and physical envi-2510 Cell Reports 15, 2510–2523, June 14, 2016 ª 2016 The Author(
This is an open access article under the CC BY-NC-ND license (http://ronment, and it is now appreciated that these changes in tumor
environment contribute to tumor development, progression, and
metastasis (Vargo-Gogola and Rosen, 2007; Schedin and Keely,
2011). Although there are many biologic processes contributing
to tumor metastasis, the capacity of tumor cells to de-adhere
from one another and other epithelial cells and then invade
through the basement membrane and migrate through the inter-
stitial space to access lymphatic and vascular channels are
clearly important first steps. Tumor cell invasion and migration
are regulated by reciprocal communicating pathways between
tumor cell and tumor-stromal components.
Womenwith highmammographicdensity,which is, inpart, due
to increased collagen deposition in the breast, have increased
risk of developing breast cancer, andwhen they do, their cancers
tend to be more invasive and exhibit poorer prognosis (Boyd
et al., 2002). Moreover, in many breast tumors, there is increased
deposition of collagen fibers and, when present, this is associ-
ated with a worse clinical outcome (Schedin and Keely, 2011).
In addition to the prognostic implications of increased tumor
collagen, the presence of thick, straight, and long fibers and the
alignment of collagen fibers relative to the tumor-stromal bound-
ary (collectively termed the tumor-associated collagen signature,
or TACS) are also correlatedwith invasive disease andpoor prog-
nosis (Provenzano et al., 2006, 2008). Despite these clinical asso-
ciations or correlations, the molecular and cellular mechanisms
responsible for increased collagen fiber deposition and collagen
fiber remodeling in tumors remain undefined.
Recently, the fibrillar collagen receptor discoidin domain
receptor 2 (DDR2) was found to influence breast tumor cell inva-
sion in 2D and 3D culture models as well as breast tumor metas-
tasis in syngeneic and xenogenic orthotopic transplant models
(Zhang et al., 2013; Ren et al., 2014). Normal human breast
epithelium does not express DDR2, but 50%–70% of invasive
ductal carcinomas express DDR2 (Zhang et al., 2013; Toy
et al., 2015). DDR2 expression has also been detected in stromals)
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cells around the tumor (Zhang et al., 2013; Toy et al., 2015). The
cellular action of DDR2 has been implicated in collagen synthesis
and extracellular matrix (ECM) remodeling (Ferri et al., 2004;
Sivakumar and Agarwal, 2010), endothelial cell (EC) functions
(Zhang et al., 2014), dendritic cell activation (Lee et al., 2007),
and neutrophil migration (Afonso et al., 2013). Targeted ubiqui-
tous deletion of the Ddr2 gene or spontaneous mutations in
the Ddr2 gene in mice (slie mouse) result in dwarfism due to
reduced chondrocyte proliferation during early bone develop-
ment and impaired wound healing due to defective cell migration
(Labrador et al., 2001; Kano et al., 2008). Ddr2-null mice are also
infertile due to defects in spermatogenesis and ovulation (Kano
et al., 2008, 2010; Matsumura et al., 2009).
To understand the cellular basis for DDR2’s action in the regu-
lation of breast cancer metastasis, we used a genetic approach
in mouse models of breast cancer metastasis. We generated
a number of Ddr2 mouse alleles, including a conditional allele
and a cell-marker-tracking allele. We found that the action of
DDR2 in both primary tumor cells and primary tumor stromal
cancer-associated fibroblasts (CAFs) is critical for breast cancer
metastasis in the mouse mammary tumor virus-polyoma middle
T antigen (MMTV-PyMT)mousemodel, without affecting primary
tumor growth.
RESULTS
Generation and Characterization of Modified DDR2
Alleles in Mice
To determine the cellular basis of DDR2 action in breast
cancer metastasis in vivo, we generated multiple Ddr2 alleles
using targeted embryonic stem cells obtained from the Euro-
pean Conditional Mouse Mutagenesis Program (EUCOMM).
The mouse Ddr2 gene is located on chromosome 1, contains
19 exons, and encodes a single transcript that produces just
one protein isoform. The EUCOMM-targeted Ddr2 allele con-
tains a lacZ reporter gene and a neomycin gene, each with poly-
adenylation sequences that terminates transcription. These
cassettes are inserted between exons 7 and 9 of the Ddr2
gene, which encode for a portion of the extracellular DS-like
domain. Two FRT sites bracketing the lacZ and neomycin se-
quences and three loxP sites allow for the generation of either
a null allele or a conditional allele when recombined (Figure 1A).
The original targeted allele is a Ddr2-null that expresses lacZ
under the control of Ddr2 transcriptional regulatory elements
(Ddr2null). To enhance expression of lacZ, we crossed the original
Ddr2 allele to b-actin-Cre mice to excise the neomycin gene and
exon 8 (Ddr2lacZ; Figures 1A and S1A), thereby generating
another Ddr2-null allele.
To generate a conditional allele, we crossed the original Ddr2
allele to FLPO transgenic mice, which resulted in the deletion of
the lacZ and neomycin cassette, leaving two loxP sites flanking
exon 8 (Ddr2fl; Figures 1A and S1B). Subsequent Cre-mediated
recombination of the two remaining loxP sites resulted in the
deletion of exon 8 and a frameshift mutation that introduced a
stop codon in exon 10,which encodes for part of the extracellular
domain of DDR2 just outside the transmembrane region (Ddr2).
To generate ubiquitous DDR2-null mice, we crossed the orig-
inal Ddr2null/+ founders. Ddr2null/null mice were 25% smaller thantheir wild-type (WT) littermates (Figures 1B and 1C) and sterile,
as previously reported (Labrador et al., 2001; Kano et al.,
2008). Ddr2lacZ/lacZ and Ddr2/ mice were also dwarves and
infertile. Western blot analysis of dermal fibroblasts isolated
from Ddr2null/null mice confirmed deletion of the DDR2 protein
(Figure 1D). Homozygous conditional Ddr2fl/fl mice did not
display any phenotypic abnormalities and bred in normal Men-
delian ratios. When these mice were crossed with b-actin-Cre
to produce ubiquitous Ddr2/mice, PCR analysis revealed suc-
cessful deletion of the floxed exon 8, indicating that the loxP sites
are functional in vivo (Figure 1E). These Ddr2/ mice were also
dwarves and infertile. Western blot analysis of dermal fibroblasts
isolated from these mice also revealed deletion of the DDR2 pro-
tein (Figure 1F). Mammary gland development was not affected
by Ddr2 gene deletion in all three ubiquitous DDR2-null mice
(Figures S1C–S1E). Both mammary ductal branching and termi-
nal end bud numbers were unchanged from WT littermates.
Ubiquitous Deletion of DDR2 Reduces Breast Cancer
Metastasis to the Lungwithout Affecting Primary Tumor
Growth
MMTV-PyMT transgenicmice developmultifocal primary tumors
in the mammary glands beginning as early as 3 weeks of age,
and over 90% of these mice go on to develop lung metastases
(Guy et al., 1992; Kim and Baek, 2010). Tumors progress through
stages similar to human breast cancer: hyperplasia, adenoma,
and, finally, invasive adenocarcinoma and metastases (Kim
and Baek, 2010). To determine whether DDR2 influenced breast
cancer development and metastasis in genetic mouse models,
we generated ubiquitous Ddr2null/null; MMTV-PyMT mice. There
was no difference in latency of primary tumor formation or time
(14 weeks) for tumors to reach maximum size (2 cm) between
Ddr2+/+ and Ddr2null/null mice (Figure 2A). DDR2 deletion did
not affect the number of primary tumors or total primary tumor
burden per mouse (Figures 2B and S2A). There was no differ-
ence in level of Ki-67 staining in primary tumors from Ddr2+/+
versus Ddr2/ mice (Figure S2B). These results indicated that,
in vivo, the action of DDR2 did not affect growth of primary
tumors in the MMTV-PyMT mouse model of breast cancer.
In stark contrast, there was dramatic reduction in the num-
ber of macroscopic and microscopic metastases in the lungs
of Ddr2null/null mice (Figures 2C and S2C). Similar results
were obtained with three different ubiquitous DDR2-null mice
(Ddr2null/null, Ddr2lacZ/lacZ, and Ddr2/) (Figure 2C). When pre-
sent, we did not observe any difference in the average size of
individual lung metastases, between WT and DDR2-null mice
(Figure S2D). These data indicated that DDR2 played a critical
role in the progression of breast cancer to lung metastasis in
the MMTV-PyMT mouse model.
Both Tumor and Tumor-Associated Stromal Cells
Express DDR2 as Breast Tumors Develop, Progress, and
Metastasize
Immunohistochemistry (IHC) analyses of human breast cancers
have revealed that DDR2 is expressed in the majority of invasive
ductal carcinoma cells yet not in normal breast epithelial tissue
(Zhang et al., 2013; Toy et al., 2015). Given that available mouse
DDR2 antibodies do not specifically detect DDR2 in mouseCell Reports 15, 2510–2523, June 14, 2016 2511
Figure 1. Generation and Characterization of Modified Mouse DDR2 Alleles
(A) Schematic of Ddr2 alleles. Ddr2null mice were crossed with b-actin-Cre mice to generate the Ddr2lacz allele. Ddr2null mice were crossed with FLPO mice to
generate the conditional floxed allele (Ddr2fl).
(B) Body weights of various mice, calculated as percentage of WT littermate. *p < 0.001, ten mice per group. Data are presented as mean ± SD.
(C) Representative images confirming the dwarfism phenotype in Ddr2/ mice.
(D) Western blot of extracts from dermal fibroblasts isolated from Ddr2+/+ and Ddr2null/null mice with indicated antibodies.
(E) PCR detection of floxed and recombined DDR2 alleles in dermal fibroblasts isolated from indicated mice.
(F) Western blot of extracts from dermal fibroblasts isolated from indicated mice, with the indicated antibodies.
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Figure 2. Ubiquitous Deletion of DDR2
Reduces Breast Cancer Lung Metastasis
without Affecting Primary Tumor Growth
(A) Primary MMTV-PyMT tumor growth rates in
indicatedmice, determined by the age at which the
largest tumor reached 2 cm in diameter. 10–40
mice per group. Data are presented as mean ± SD.
(B) Total tumor burden of indicated mice, deter-
mined by the sum of the volume of all tumors for
each mouse when the largest tumor reached 2 cm
in diameter. Tumor volumes were calculated by V =
0.52 3 (W2) 3 L. 10–40 mice per group. Data are
presented as mean ± SD.
(C) Quantification of number of lung metastases in
indicatedmice calculated by the average number of
microscopically visible metastases counted from
three H&E-stained sections of lung from each
mouse taken 200 mm apart and normalized to the
total lungarea. *p<0.01;N.S., not significant. 10–40
mice per group. Data are presented as mean ± SD.tissues by IHC or immunofluorescence (IF), we made use of the
Ddr2lacZ allele to track DDR2 expression during MMTV-PyMT
breast cancer development. X-gal staining revealed low-level
DDR2 expression in stromal cells of normal mammary gland,
but no staining was apparent in normal breast epithelial cells
(Figure 3A). DDR2 expression (LacZ) was detected in MMTV-
PyMT tumor cells of early hyperplastic lesions, adenomas, and
adenocarcinomas (Figure 3A). Higher magnification views of
early hyperplastic lesions revealed that most DDR2-expressing
tumor cells were at the ductal-stromal interface (Figure 3B). In
addition, both luminal and basally located epithelial tumor cells,
and tumor-associated stromal cells stained positive for X-gal
(Figure 3B). DDR2 expression was also present in metastatic
lung tumors but not normal lung epithelium (Figures S2E
and S2F).
To confirm the identity of DDR2-positive cells in breast tumor,
we performed X-gal and IF staining on serial sections, using
antibodies specific for basal myoepithelial cells (alpha-smooth
muscle actin [a-SMA] and cytokeratin 14 [K14]) and luminal
epithelial cells (cytokeratin 8 [K8]). DDR2 was detected in both
luminal (K8+) and basal (K14+) epithelial-like tumor cells in hyper-
plastic lesions (Figure 3C). To co-localize DDR2 expression with
specific cell markers in the same tissue slice, we performed dual-
color in situ hybridization (ISH) for mRNA. This analysis also
revealed that DDR2 was expressed in K8+ and K14+ cells in
13-week MMTV-PyMT breast carcinomas (Figure 3D).
Breast tumor stromal cell expression of DDR2 has been
observed in human breast cancer, but the precise identity ofCell Rthese cells has not been determined
(Zhang et al., 2013; Toy et al., 2015).
Dual-color ISH with fibroblast activation
protein (FAP) (to detect CAFs) and DDR2
revealed that DDR2 was expressed in
stromal CAFs (Figure 6B). This was
confirmed by western blot analysis of iso-
lated primary human breast CAFs (Fig-
ure 6A). Dual ISH with the pan-leukocyte
marker (CD45) and DDR2 gave ambig-uous results, so we sorted for CD45+ cells from 13-week WT
breast carcinomas and then performed qPCR for DDR2 and
GAPDH controls. DDR2 mRNA was detected in CD45+ tumor-
associated stromal cells (Figure S2G).
These analyses in mouse MMTV-PyMT breast tumors at mul-
tiple stages of development revealed that, like human breast
tumors, DDR2 was not expressed in normal breast epithelial
cells, but both luminal and basal epithelial cells expressed
DDR2 in tumors. In the tumor stroma, DDR2 was expressed
in CAFs and CD45+ pan-leukocyte cells. Lung metastases also
expressed DDR2.
Action of DDR2 in Basal, but Not Luminal, Breast
Epithelial Cells Is Critical for Lung Metastasis
Next, we set out to determine the contribution of the action of
DDR2 in luminal and basal-like tumor epithelial cells to primary
breast tumor growth and metastasis in a mouse genetic model.
To do so, the Ddr2 gene was selectively deleted in mammary
luminal epithelial cells using MMTV-Cre or in basal and luminal
epithelial cells using K14-Cre (Dassule et al., 2000; Wagner
et al., 2001). Although K14 expression is restricted to basal cells
soon after birth, during early stages of mammary gland develop-
ment, K14 is expressed in both basal and luminal epithelial cells
(Van Keymeulen et al., 2011); therefore, K14-Cre allows for dele-
tion of Ddr2 in both breast epithelial cell types.
Ddr2fl/fl;MMTV-Cre andDdr2fl/fl; K14-Cremicewere crossed to
MMTV-PyMT mice. In agreement with results from ubiquitous
Ddr2-null mice, we observed no differences in primary tumoreports 15, 2510–2523, June 14, 2016 2513
Figure 3. DDR2 Expression in Mouse MMTV-PyMT Breast Tumor Development and Progression
(A) X-gal staining of mammary gland/tumor sections from Ddr2lacZ/+; MMTV-PyMT mice at multiple times during tumor development. Scale bars, 50 mm.
(B) X-gal staining on hyperplastic mammary glands from 5-week-old Ddr2lacZ/+; MMTV-PyMT mice. Scale bars, 50 mm. Arrowhead indicates stromal cell, black
arrow indicates luminal epithelial cell, and red arrow indicates basal myoepithelial cell.
(C) X-gal staining and immunofluorescence for K14 (yellow), K8 (green), and a-SMA (red) on sequential tissue slices from hyperplastic mammary glands: 5-week-
old Ddr2lacZ/+; MMTV-PyMT mice. Scale bars, 50 mm.
(D) Dual in situ hybridization for mRNA (left) of 13-week primary breast tumor slices from Ddr2+/+; MMTV-PyMT mice. K14 (red) and DDR2 (green) stain in the top
panels and K8 (red) and DDR2 (green) stain in the bottom panels. White arrows on H&E-stained images (right) identify cells expressing both transcripts. Scale
bars, 50 mm.
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Figure 4. DDR2 Deletion in Basal, but Not
Luminal, Breast Epithelial Cells Inhibit Lung
Metastasis
(A) Primary tumor growth rates in indicated mice,
determined by the age at which the largest tumor
reached 2 cm in diameter. 15–35 mice per group.
Data are presented as mean ± SD.
(B) Total tumor burden of indicated mice, deter-
mined by the sum of the volume of all tumors for
each mouse when the largest tumor reached 2 cm
in diameter. Tumor volumes were calculated by V =
0.52 , (W 2^) , L. 15–35 mice per group. Data are
presented as mean ± SD.
(C) Quantification of lung metastases in indicated
mice presented as the average number of micro-
scopically visible metastases counted from three
H&E-stained sections of lung from each mouse
taken 200 mm apart, normalized to the total lung
area. *p < 0.01; N.S., not significant. 15–35 mice
per group. Data are presented as mean ± SD.growthor total primary tumorburden for eitherCre transgene (Fig-
ures 4A and 4B). Surprisingly, in mice in which DDR2was deleted
usingMMTV-Cre, therewas no significant effect on the number of
lungmetastases (Figure 4C). In contrast, whenDDR2was deleted
with K14-Cre, therewas a statistically significant reduction in lung
metastasis, but not to the level observed when Ddr2 was ubiqui-
tously deleted (Figure 4C versus Figure 2C).
These disparate results were unexpected, as MMTV-PyMT
tumors develop from luminal mammary epithelial cells. Since
the Ddr2fl/fl allele was in a mixed C57BL/6/FVBn background,
this could account for the observed difference in metastatic
phenotypes between MMTV-Cre- and K14-Cre-deleted Ddr2.
To address this, we analyzed the number of lung metastases
according to the percentage of FVB/n background (Figures
S3A–S3C). The results were consistent, regardless the degree
of backcrossing to FVB/n, showing a statistically insignificant
reduction of lung metastasis when DDR2 was deleted in the
MMTV-Cre line. Another possibility could be that MMTV-Cre
expression was less efficient than K14-Cre. To test this, we
measured the recombination of the conditional allele by PCR
in mouse endothelial cells (MECs) isolated from MMTV-Cre,
Ddr2fl/fl and K14-Cre, Ddr2fl/fl mice (Figure S3D). In both lines,
over 90% of the DDR2 gene was recombined compared to
Ddr2fl/fl control. MMTV-Cre and K14-Cre expression patterns
were further confirmed, using the ROSA-LSL-TdTomato reporter
allele (Madisen et al., 2010). In normal adult mammary glands,
there was luminal expression of Tomato in MMTV-Cre mice,
and luminal and basal expression in K14-Cre mice, as antici-
pated (Figures S3E–S3G). MMTV-Cre and K14-Cre expressionCell Rin breast tumors showed that all MMTV-
PyMT tumors expressed Tomato. All
lung metastatic foci identified in H&E-
stained sections from both MMTV-Cre
and K14-Cre mice were also Tomato
positive (Figure S3F).
In sum, these analyses demonstrated
that the loxP sites were functional in vivo
and that expression of both MMTV-Creand K14-Cre was efficient and equivalent. Thus, differences
in MMTV-Cre and K14-Cre expression likely did not explain the
difference in metastatic phenotype.
Action of DDR2 in Cells within the Tumor Environment Is
Also Important for Breast Cancer Metastasis
Selective deletion of DDR2 in breast epithelial cells (K14-Cre)
did not inhibit lung metastasis to the same extent as when
DDR2 was ubiquitously deleted. This raised the possibility
that the action of DDR2 in cells within the tumor stroma or envi-
ronment may also contribute to breast cancer metastasis. To
determine whether this is the case, we performed reciprocal
transplant experiments using primary breast tumor cells iso-
lated from Ddr2+/+; MMTV-PyMT or Ddr2/; MMTV-PyMT
mice that were implanted into the mammary fat pads of synge-
neic Ddr2+/+ or ubiquitous Ddr2/ recipient mice. Regardless
of tumor or host Ddr2 genotype, transplanted primary breast
tumors reached 2 cm in diameter between 6 and 10 weeks
post-implantation (Figure 5A). Histological analysis of lungs
once primary breast tumor reached 2 cm revealed lung metas-
tases in control Ddr2+/+ recipients transplanted with Ddr2+/+
tumor cells (Figure 5B). WT Ddr2 recipients of Ddr2/ tumor
cells had reduced lung metastases consistent with a role
for DDR2 in tumor cells (Figure 5B). However, interestingly,
when Ddr2/ mice were transplanted with Ddr2+/+ tumor cells,
lung metastases were dramatically inhibited as well (Figure 5B).
This indicated that the action of DDR2 within cells of the host
tumor environment also contributed to DDR2’s ability to regu-
late breast cancer metastasis.eports 15, 2510–2523, June 14, 2016 2515
Figure 5. The Action of DDR2 in the Tumor
Stroma Is Critical for Metastasis
(A and B) Reciprocal transplant of MMTV-PyMT
primary tumors cells from the indicated genotypes
were transplanted into the breasts of syngeneic
(FVBn) hosts of the indicated genotype. Time to the
development of a 2-cm breast tumor was scored
(A). 8–11 mice per group. Quantification of lung
metastases as the average number of microscop-
ically visible metastases counted from three H&E-
stained sections of lung from each mouse taken
200 mm apart normalized to the total lung area (B).
*p < 0.01; N.S., not significant. 8–11 mice per
group. Data are presented as mean ± SD.
(C) Picrosirius red staining on tumor sections from
Ddr2+/+; MMTV-PyMT and ubiquitous Ddr2/;
MMTV-PyMT mice. Scale bars, 100 mm.
(D) Quantification of Picrosirius red staining from
(C). Positive staining was calculated as the per-
centage of red pixels over the total number of
pixels in the image. *p < 0.001. Data are presented
as mean ± SD.
(E) Representative second-harmonic-generation
images of collagen organization in 10- to 13-week
tumors from Ddr2+/+ and ubiquitous Ddr2/mice.
Curly collagen fibers (left image) were scored as
TACS-1, and straight collagen fibers (right image)
were scored as TACS-2/3.
(F) Percentage of images scored as TACS-1 or
TACS-2/3 from Ddr2+/+ PyMT tumors and Ddr2/
PyMT tumors. Three 13-week and four 10-week
mice of each genotype were analyzed. Three or
four tumors from each mouse were isolated, and
three to four images from each tumor were ac-
quired. Total of 77 images scored. Student’s t test,
*p < 0.05. Data are presented as mean ± SD.Ubiquitous Deletion of DDR2 in Breast Tumors Is
Associated or Correlated with Less Advanced or
Aggressive Primary Tumors
To determine how the action of DDR2 in tumor and tumor stromal
cells could impact the primary tumor environment, we performed
Picosirius Red staining to assess the extent of fibrillar collagen
deposition. MMTV-PyMT primary tumors are typically highly
fibrotic, and increased fibrillar collagen deposition within primary
tumors is a poor prognostic factor. In ubiquitous Ddr2/;
MMTV-PyMT primary tumors, there was significant reduction
in total fibrillar collagen (Figure 5C; quantified in Figure 5D),
whereas primary breast tumors from Ddr2fl/fl; MMTV-Cre;
MMTV-PyMT and Ddr2fl/fl; K14-Cre; MMTV-PyMT mice did not
show a reduction in fibrillar collagen levels (Figure 5D).
Certain features about collagen architecture within the tumor
stroma (e.g., fiber orientation, thickness, linearity) are associated
with poor clinical outcomes. Collagen fiber structure in primary
breast tumors was assessed by second-harmonic generation
(SHG) microscopy on tissue sections from 10- to 13-week tu-
mors. Multiple primary breast tumors per mouse from multiple2516 Cell Reports 15, 2510–2523, June 14, 2016mice were scored for their TACS, as
described previously (Provenzano et al.,
2006). Ddr2+/+; MMTV-PyMT tumors ex-
hibited predominantly TACS2/3 scores(more linear, thicker collagen fibers), consistent with aggressive
and invasive tumors (Figure 5E; quantified in Figure 5F). In
contrast, age-matched ubiquitous Ddr2/; MMTV-PyMT tu-
mors exhibited predominantly a TACS1/2 score (curly collagen
fibers) that is associated with less aggressive tumors (Figure 5E;
quantified in Figure 5F).
Increasedprimary tumor vasculaturecanpromote tumorcell in-
vasion and metastatic disease (Moserle and Casanovas, 2013).
Ddr2+/+; MMTV-PyMT tumors were found to have significantly
higher CD31 staining than that of ubiquitous Ddr2/; MMTV-
PyMT tumors (Figure S4A; quantified in Figure S4B). Another ma-
jor constituent of the tumor stroma are immune cells, which can
promote or inhibit tumor progression and invasion (Grivennikov
et al., 2010). We enumerated immune cell infiltrates in Ddr2+/+;
MMTV-PyMT and ubiquitous Ddr2/; MMTV-PyMT primary
breast tumors and found no difference in the number of immune
cells in 13-week and20-week primary tumors (Figures S4C–S4H).
Histologic comparison of Ddr2+/+ and ubiquitous Ddr2/ pri-
mary tumors (at 10 weeks) revealed significantly less advanced
carcinomas in Ddr2/ tumors (Figures S5A and S5B; quantified
Figure 6. The Action of DDR2 in CAFs Regu-
lates Production of Tumor-Associated ECM
(A) Western blot for DDR2, SNAIL1, a-SMA, and
FSP1 proteins in normal human breast fibroblasts
or human breast CAFs.
(B) Dual in situ hybridization for mRNA (left) of
13-week primary breast tumor slices from Ddr2+/+;
MMTV-PyMT mice. FAP (red) and DDR2 (green).
White arrows on H&E-stained images (right) iden-
tify cells within the tumor stroma that express both
transcripts. White arrowheads identify tumor cells
expressing DDR2 mRNA. Scale bars, 50 mm.
(C) Immunofluorescence staining for collagen 1a1
matrix produced by mouse breast tumor CAFs.
Scale bars, 50 mm.
(D) Quantification of global fiber alignment in (C).
Data are presented as mean ± SD.
(E) Immunofluorescence staining for fibronectin
matrix produced by normal human mammary fi-
broblasts (left), human breast tumor CAFs (control
SCR shRNA; middle), or hCAFs depleted of DDR2
by shRNA (right). Scale bars, 50 mm.
(F) Quantification of global fiber alignment in (E).
Data are presented as mean ± SD.
(G) qPCR analysis of mRNA isolated from human
CAFs, short hairpin (sh) RNA (shRNA) depleted
of DDR2, or transduced with scrambled control
(SCR). Multiple replicates of each gene were per-
formed for each experiment. Data are representa-
tive of two independent experiments. Data are
presented as mean ± SD. *p < 0.01.in Figure S5C). It should be noted, however, that this histologic dif-
ferencewasnotapparent in14-weekand terminal (18- to20-week)
tumors, likely because at this time point in tumor progression they
are so advanced, occupying almost the entire breast tissue.
Despite the presence in Ddr2/ primary tumors of numerous his-
tologic featuresassociatedwith lessaggressiveor invasive tumors
(e.g., decreased fibrosis, decreased angiogenesis, and more
benign stromal TAC signature), we did not detect a difference in
the number of circulating tumor cells (CTCs) between Ddr2+/+
and Ddr2/ tumor-bearing mice (Figures S5D and S5E). This
may reflect the wide variance in results per mouse or that reliable
detection of CTC required analyzing mice at the terminal stage of
breast tumor development (18- to 20-week tumors in PyMT and
2-cm tumor in the 4T1 transplant model) when primary tumors in
both Ddr2+/+ and Ddr2/mice all exhibit advanced carcinoma.
When considered in the aggregate, these analyses of Ddr2/
primary breast tumors weremostly associated with or correlatedCell Rwith less advanced or aggressive primary
tumors suggesting that theaction ofDDR2
in the primary tumor (tumor cells and tu-
mor stromal cells) affected metastasis.
The Action of DDR2 in CAFs Is
Critical for Production of Tumor-
Associated ECM
In contrast to tumors ubiquitously deleted
of DDR2, selective deletion of DDR2 in
breast epithelial cells (MMTV-Cre or K14-Cre)wasnot associatedwith any change in tumormatrix collagen
(Figure 5D). This implicates the action of DDR2 in tumor stromal
cells as responsible for observed changes in tumor matrix or
collagen fibers. Knowing that CAFs are the major source of
collagen production in breast tumors (Bhowmick et al., 2004)
and that DDR2 was expressed by CAFs, we asked whether the
action of DDR2 in CAFs affected ECM production and remodel-
ing. We isolated and purified primary CAFs from DDR2+/+ and
ubiquitous DDR2/ mouse PyMT breast tumors as well as
depleted DDR2 from human breast tumor CAFs with specific
short hairpin (sh)DDR2 RNAi.
DDR2 expression was increased in breast CAFs compared to
normal breast fibroblasts (Figure 6A). ISH analysis of Ddr2+/+;
MMTV-PyMT tumors revealed that DDR2 mRNA was expressed
in FAP+ CAFs (Figure 6B). WT CAFs produced a highly aligned,
or ordered, collagen I and fibronectin matrix (Figures 6C and 6E).
Depletion of DDR2 led to a significant change in the global ordereports 15, 2510–2523, June 14, 2016 2517
of the ECM fibers, producing an ECM similar to that of normal
mammary fibroblasts (Figure 6E). The degree of global order of
matrix fibers was measured using a sub-window 2D Fourier
transform method (Figures 6D and 6F; Figures S5F–S5I) (Cetera
et al., 2014; Sander and Barocas, 2009). Real-time qPCR anal-
ysis of select fibrogenic gene expression by WT and Ddr2/
CAFs revealed a significant reduction in the expression of
several collagen genes, collagen-modifying genes (lysyl oxi-
dases; LOX), and matrix-remodeling enzymes (metalloprotei-
nases; MMPs) in CAFs depleted of DDR2 (Figure 6G).
These data demonstrated that the action of DDR2 in CAFs
is critical for ECM production and remodeling. When coupled
with SHG analysis of collagen fibers in primary tumors, this
indicated that the action of DDR2 in tumor CAFs, and possibly
other stromal cells, is critical for production of the tumor
stromal ECM.
TheAction of DDR2 inBothK14+ TumorCells and Tumor
Stromal CAFs Is Critical for Collective Invasion/
Migration of Primary Tumor Organoids
Tumor-cell-based culture studies (in 2D and 3D) have described
a critical role for DDR2 in regulating tumor cell invasion and
migration (Zhang et al., 2013). K14+ cells within breast tumors
are thought to lead collective invasion of tumor cells (Cheung
et al., 2013). Thus, we hypothesized that the decrease in lung
metastasis in ubiquitous Ddr2/ and K14-Cre-deleted DDR2
tumors was a result of reduced collective invasion regulated by
K14+ tumor cells. To test this, we utilized a tumor organotypic
3D culture system (Nguyen-Ngoc et al., 2012). To model normal
breast epithelial environment, tumor organoids were cultured in
3D Matrigel, while to model the stromal matrix invading/
migrating tumor cells encounter, tumor organoids were cultured
in 3D collagen I gels. In these culture systems, K14+ tumor cells
acquire leader cell behavior when tumor organoids are cultured
in 3D collagen I gels and give rise to invasive protrusions (Cheung
et al., 2013).
When primary tumor organoids from Ddr2+/+ and Ddr2/
mice were plated on normal tissue culture plates (2D cultures),
both grew in cobblestone islands characteristic of epithelial cells
(Figure S6A), and there was no change in proliferation rates be-
tween them (Figure S6B). In collagen I gels, there was a dramatic
reduction in the number of invasive tumor organoids present
when DDR2 was deleted in all cells within the tumor or with
K14-Cre, but not MMTV-Cre (Figure 7E). In Matrigel, tumor orga-
noids from ubiquitous Ddr2/; MMTV-PyMT tumors exhibited
reduced budding and branching, while deletion of DDR2 in tumor
cells with either MMTV-Cre or K14-Cre had no effect on tumor
organoid budding and branching (Figure S6C; quantified in
Figure S6D).
A trivial explanation for the effect of DDR2 gene deletion upon
tumor organoid invasiveness could be that DDR2 affects K14+
cell fate; thus, fewer K14+ leader cells are present. However
ubiquitous absence of DDR2 did not affect the number of
K14+ tumor cells per tumor organoid compared to WT tumor or-
ganoids (Figure S6E; quantified in Figure S6F). We also analyzed
Ddr2/ primary tumors for any change in the level of a-SMA, K8,
and K14 staining. We did not observe any differences in the
numbers of these cell populations between Ddr2+/+; MMTV-2518 Cell Reports 15, 2510–2523, June 14, 2016PyMT and Ddr2/; MMTV-PyMT primary breast tumor (Figures
S7A–S7F).
Tumor organoids contain not only tumor cells but also tumor
stromal cells such as CAFs, and CAFs can influence tumor cell
invasiveness through paracrine mechanisms, ECM production,
and ECM remodeling. IF analysis with anti-FAP antibodies
revealed that 23% of WT tumor organoids contain FAP+ cells
(CAFs) (Figure S6G; quantified in Figure S6H) and that all FAP+
cells were located at the tumor-stromal boundary of tumor
organoids.
To determine whether the action of DDR2 in CAFs influenced
paracrine functions of CAFs that support or enhance collective
tumor cell invasion in collagen I gels, we performed mixing
studies. Addition of WTCAFs toWTMMTV-PyMT tumor organo-
ids increased the number of invasive tumor organoids detected
(Figure 7B versus Figure 7C; quantified in Figure 7E). This effect
required the presence of DDR2 in CAFs, as when DDR2/CAFs
were added to WT tumor organoids, there was no change (in-
crease or decrease) in the number of invasive tumor organoids
(Figure 7C versus Figure 7D; quantified in Figure 7E). K14-Cre-
deleted DDR2 tumor organoids, but not MMTV-Cre-deleted
DDR2 tumor organoids, also exhibited a dramatically reduced
number of invasive colonies (equivalent to ubiquitous Ddr2/
tumor organoids) (Figure 7E). Surprisingly, the addition of WT
CAFs to ubiquitous Ddr2/ tumor organoids and K14-Cre-
deleted DDR2 tumor organoids rescued the invasive phenotype,
but only to the level observed with WT tumor organoids alone,
not to the level of WT tumor organoids plus WTCAFs (Figure 7E).
This effect was DDR2 dependent, as the addition of Ddr2/
CAFs did not rescue invasiveness of either ubiquitous Ddr2/-
or K14-Cre-deleted DDR2 tumor organoids.
These analyses revealed a tumor cell-intrinsic function of
DDR2 in K14+ cells that influenced collective cell invasion/migra-
tion of tumor organoids in 3D collagen I gels. In addition, the
action of DDR2 in CAFs influenced collective invasiveness of
primary breast tumor organoids through a signaling pathway
(or pathways) in tumor cells distinct from the tumor-cell-intrinsic
function of DDR2.
DISCUSSION
We have demonstrated that the action of the collagen receptor
DDR2 in both tumor cells and tumor stromal cells within the pri-
mary tumor environment is critical for breast cancer metastasis
in genetically engineered mouse models (GEMMs) of cancer.
We also observed that the action of DDR2, a receptor tyrosine ki-
nase, did not influence growth or proliferation of primary tumors
in vivo. We have identified three cellular functions for DDR2
within cells within the primary tumor: (1) In K14+ tumor cells,
DDR2 plays a cell-intrinsic role regulating tumor collectivemigra-
tion. (2) In CAFs, the action of DDR2 is critical for the production
and remodeling of the tumor matrix ECM. (3) Also, in CAFs, the
action of DDR2 provides a signal that positively influences tumor
collective migration, and this signal is distinct from DDR2’s
tumor cell-intrinsic regulation of tumor collective migration.
Despite inhibiting collective cell invasion and migration of
primary tumor organoids in collagen I and epithelial branching
in Matrigel, we did not observe any defect in mammary gland
Figure 7. Action of DDR2 in K14+ Tumor Epithelial Cells and CAFS Regulate Collective Invasion by Primary Tumor Organoids
(A-D) Representative images of tumor organoids scored. (A) Non-invasive tumor organoid, no added CAFs. (B) Invasive WT tumor organoid, no added CAFs. (C)
Invasive WT tumor organoid cultured in the presence of WT breast CAFs. (D) InvasiveWT tumor organoid cultured in the presence of Ddr2/ breast CAFs. Scale
bars, 100 mm.
(E) Quantification of number of invasive tumor organoids as a percentage of total organoids scored. In each well, 30 organoids were scored. All experimental
conditions were performed in triplicate. The experiment was performed three separate times. **p < 0.001; NS, no significant difference.
Data are presented as mean ± SD.morphogenesis during the development of Ddr2/ mice. This
may be explained by the observation that DDR2 is not expressed
in normal mammary ECs.
Within tumor cells, the action of DDR2 was not required in
luminal cells. However, deletion of DDR2 driven by K14-Cre
had a significant effect on tumormetastasis in vivo andmigrationin 3D collagen I. Although MMTV-Cre deletes DDR2 in luminal
cells, K14-Cre deletes DDR2 in luminal and basal cells (Fig-
ure S3G) (Van Keymeulen et al., 2011; Mitchell and Serra,
2014). DDR2 might need to be deleted in both populations to
affect significant reduction in lung metastasis. It is also possible
that the cells critical for metastasis spread are the K14+ cells.Cell Reports 15, 2510–2523, June 14, 2016 2519
Recent work has identified K14+ cells as leader cells critical for
collective invasion/migration in vitro and in human breast can-
cers (Cheung et al., 2013). It has also been shown that the cells
leading the collective migration are derived from the bulk of the
tumor by expressing a set of basal genes, including K14 (Cheung
et al., 2013). In the context of theMMTV-PyMT, K14-Cre, Ddr2fl/fl
mice, this suggests that DDR2 would be deleted in all the cells
that are leading migration. This might indicate that the action
of DDR2 is required only in the K14+ epithelial cells and suggest
that the tumor-cell-intrinsic role for DDR2 was predominantly to
control tumor cell collective invasion/migration by K14+ leader
cells. MMTV-PyMT, K14-Cre, Ddr2fl/fl tumor organoids showed
reduced invasion in collagen I (Figure 7E) but no significant
reduction of branching in Matrigel (Figures S6C and S6D). Since
it has been suggested that the K14+ cells acquire leader cell be-
haviors specifically in collagen I microenvironments (Cheung
et al., 2013), this might indicate that DDR2 role in K14+ is impor-
tant mostly in leader cells in the collagen-I-rich tumor stromal
environment.
The action of DDR2 in K14+ tumor cells was critical for the
invasive program of primary tumor organoids in 3D collagen I
gels. DDR2 signals could regulate tumor cell collective invasion
in K14+ cells by stabilizing the EMT factor SNAIL1, thereby
maintaining an invasive EMT phenotype (Zhang et al., 2013).
Whether the action of DDR2 in leader K14+ basal-like tumor
cells requires SNAIL1 or is independent of SNAIL1 remains to
be determined, but it has been argued that the invasive pro-
gram of primary tumor organoids can occur independently of
some EMT factors and that tumor cells remain E-cadherin pos-
itive (Cheung et al., 2013). However, increasing evidence sup-
ports the plasticity of the EMT phenotype and, therefore, tumor
cells may exist in dynamic partial epithelial or mesenchymal
states (Savagner, 2015). In the PyMT breast tumor model, virtu-
ally all primary breast tumors are SNAIL1 positive (Tran et al.,
2014), so it remains to be determined whether DDR2 has as
dramatic an effect upon metastasis in other mouse models of
breast cancer where expression of SNAIL1 is not as prevalent.
Recent IHC analysis of human breast cancers found high levels
of DDR2 associated with high tumor grade, triple-negative
breast cancer (TNBC), and worse survival (Toy et al., 2015).
TNBC of the basal or claudin-low subtypes are more likely to
express SNAIL1.
A common feature of primary breast tumors is an increased
abundance of ECM deposition (especially fibrillar collagens),
which, when present, is associated with increased risk of inva-
sive disease and shorter patient survival (Walker, 2001; Kreike
et al., 2007). MMTV-PyMT mouse breast tumors are typically
fibrotic, and ubiquitous DDR2 deletion led to significant reduc-
tion in the amount of fibrillar collagen and benign-appearing
collagen fiber architecture. Reciprocal transplant experiments
demonstrated that the action of DDR2 in the tumor environment
was also critical for breast cancer metastasis. DDR2 has been
implicated in the cellular synthesis and remodeling of fibrillar col-
lagenswithin the ECM (Ferri et al., 2004; Sivakumar and Agarwal,
2010; Zhang et al., 2013), collagen 1a1 transcription (Zhang
et al., 2013), and the expression and activation of matrix metal-
loproteinases (Leitinger, 2014). DDR2 expression has also
been shown to be increased in bleomycin-induced lung fibrosis2520 Cell Reports 15, 2510–2523, June 14, 2016and CCl4-induced hepatic fibrosis (Olaso et al., 2011; Yang et al.,
2013). All of these reports lend support to the notion that DDR2
activation promotes collagen production or remodeling in tu-
mors. CAFs are the main producers of ECM proteins and ECM
remodeling enzymes (Bhowmick et al., 2004), DDR2 expression
is activated in CAFs, and depletion of DDR2 in CAFs results
in less ECM production and altered collagen architecture—
features correlated with tumor cell invasion and metastasis.
Furthermore, Ddr2/CAFs do not support invasion of tumor or-
ganoids in collagen I. In sum, these observations implicate the
action of DDR2 in CAFs within the primary tumor as being critical
for regulation of breast cancer metastasis.
DDR2-positive CAFs could arise from tumor cell EMT, but
DDR2 is also expressed by normal human breast fibroblasts,
and expansion of resident fibroblasts is thought to be the largest
source of CAFs in tumors. Tumor cells and other stromal cells
(e.g., immune cells) could also influence collagen production
by CAFs, as factors secreted by these cells, or factors released
from ECM remodeling, can stimulate collagen production and
may be lacking in Ddr2/ cells (Walker, 2001; Kalluri and Zeis-
berg, 2006).
Another environmental aspect influencing tumor cell invasion
is physical stiffness of the ECM. Increased deposition of ECM
proteins not only changes the biochemical signals that tumor
cells encounter but also changes the physical environment
in which they grow and migrate (Schedin and Keely, 2011).
Increasing matrix stiffness promotes local invasion of mammary
epithelial organoids and enhances tumor cell migration, predom-
inantly through the Rho-ROCK pathway downstream of integrins
(Paszek et al., 2005; Schedin and Keely, 2011). Since Ddr2/;
MMTV-PyMT primary tumors have significantly less fibrillar
collagen and the fibers are less linear and thick than Ddr2+/+;
MMTV-PyMT tumors, it is possible that the tumor tissue is less
stiff, thereby also contributing to decreased tumor cell invasion
and migration.
Integrin activity in tumors is clearly critical for breast cancer
metastasis (Seguin et al., 2015). Thus, it is remarkable that ge-
netic deletion of DDR2, in the presence of integrins, has such a
dramatic effect upon metastasis. In cells in culture, DDR2 can
be activated by fibrillar collagens, even when b1-integrins are
inhibited (Zhang et al., 2013). DDR2, itself, is a poor adhesive
molecule yet can mildly affect integrin activity in cells (Xu et al.,
2012). Therefore, it remains a possibility that DDR2-integrin
crosstalk is important for tumor cell invasion or metastasis
in vivo.
Although we did not see significant changes in the numbers of
specific immune cell types in the primary tumors of Ddr2+/+;
MMTV-PyMT and Ddr2/; MMTV-PyMT mice, it is possible
that DDR2 loss could lead to changes in immune cell function.
DDR2 is expressed in neutrophils and required for neutrophil
migration through 3D collagen matrices (Afonso et al., 2013).
DDR2 also plays a role in the collagen-induced activation of den-
dritic cells (Lee et al., 2007) and is expressed in macrophages in
atherosclerotic lesions (Ferri et al., 2004), but little else is known
about the function of DDR2 in immune cells, particularly in tu-
mors. We cannot exclude the possibility that another subset
of immune cells has a role in DDR2-mediated breast cancer
metastasis.
It has been reported that DDR2 is expressed in tumor-associ-
ated human ECs and promotes the angiogenic capacity of ECs
(Zhang et al., 2014). Syngeneic transplant experiments demon-
strated a reduction in angiogenesis when B16-F10 melanoma
tumors were subcutaneously implanted into DDR2-null mice,
and these tumors had reduced mRNA levels of pro-angiogenic
factors such as Vegfr2 and Ang-2.We also observed a significant
reduction in blood vessel growth in Ddr2/; MMTV-PyMT
primary tumors. Therefore, DDR2 may promote metastasis, in
part, by stimulating blood vessel growth in primary tumors or
through regulating factors secreted by tumor or other stromal
cells that regulate angiogenesis.
In summary, our data may explain, in part, why patients with
primary breast tumors that have high levels of fibrillar collagen
deposition are associated with invasive and metastatic disease
and poorer outcomes. These studies argue that DDR2, a unique
receptor tyrosine kinase, could be an important therapeutic
target in breast cancer metastasis and that treatments selec-
tively targeting DDR2 would impact both tumor cells and tumor
environment simultaneously.
EXPERIMENTAL PROCEDURES
For more information, see the Supplemental Information.
Generation of Modified Ddr2 Alleles
Embryonic stem cells containing the targeted Ddr2 allele (Ddr2tm1a(EUCOMM)
Wtsi) were obtained from EUCOMM and injected into C57BL/6 tetraploid em-
bryos. Founder mice were crossed to b-actin-Cre mice or FLPO mice to
generate Ddr2lacZ/+ or Ddr2fl/+ alleles, respectively. Ubiquitous Ddr2-null
mice (Ddr2null/null, Ddr2lacZ/lacZ and Ddr2/) were backcrossed at least six
generations onto a pure FVB/N background. Conditional Ddr2fl/fl mice were
on a mixed FVBN/C57BL/6 background. All mice were used in compliance
with the Washington University Institutional Animal Care and Use Committee
under protocol #21020142.
Mouse Tumor Studies
Both ubiquitous and conditional Ddr2/ mice were crossed to MMTV-PyMT
mice. Conditional Ddr2fl/fl mice were crossed to K14-Cre (Jackson Laboratory,
stock #004782), MMTV-Cre, and ROSA-LSL-TdTomato mice. Tumor-bearing
mice were monitored weekly and euthanized when the largest tumor reached
2 cm in diameter. Mammary gland transplants were performed as previously
described (Zhang et al., 2013).
Analysis of Lung Metastasis
Lungs were fixed overnight in 10% formalin, then washed with 70% ethanol,
and processed and embedded in paraffin blocks. Tissue sections (5 mm)
were stained with H&E. Microscopically visible metastatic foci were counted
from three sections taken 200 mm apart and reported as the average number
of metastases per section.
SHG Image Acquisition and Analysis
Tumors from 10- to 13-week-old animals were fixed in 10% neutral buffered
formalin overnight. Collagen matrix images were observed using multiphoton
laser scanning microscopy (MPLSM) and SHG on a Bruker IV multiphoton mi-
croscope tuned to a wavelength of 890 nm. Images were focused onto a Zeiss
203 Plan Apo water-immersion lens (numerical aperture, 1.0), and SHG emis-
sion was observed at 445 nm and discriminated from fluorescence using a
445-nm emission filter with a 20-nm narrow bandpass. Three to four 20-mm
z stacks were collected with a 2-mm step size for each tumor (43 z stacks
represent 11 tumors from six Ddr2+/+ mice, and 34 z stacks represent 9 tu-
mors from five Ddr2/mice). The z stacks were compressed into one image,
and collagen fiber organization was scored by three blinded reviewers asTACS-1 (curly fibers) or TACS-2/3 (straight fibers), as described previously
(Provenzano et al., 2006). Themajority score was used for each image, percent
TACS-1 versus TACS-2/3 score was determined for each tumor, and the
average percent score was determined for Ddr2+/+ versus ubiquitous Ddr2/.
Isolation and Culture of Primary Tumor Cells and Tumor Organoids
Mouse mammary tumor organoids were isolated as previously described
(Nguyen-Ngoc et al., 2012). Primary tumor organoids (30–50, each 200–
1,000 cells) with or without CAFs (750) were cultured in 50-ml droplets of either
growth-factor-reduced Matrigel or 3 mg/ml acid-solubilized rat-tail collagen I
(BD Biosciences). Alternatively, organoids were plated on normal tissue cul-
ture plates to expand the cells and perform experiments with single cells
(transplants, transwell assay, proliferation analysis). Immunofluorescence
quantification of organoids was performed by measuring the ratio of fluores-
cein isothiocyanate (FITC) to DAPI signal intensity within annular regions of
interest extending from the organoid surface to 17 mm (50 pixels) into the orga-
noid to focus on expression in the outermost layer of cells. These regions of
interest were identified using automated intensity and distance thresholding
implemented in a custom MATLAB program.
Isolation of CAFs
MMTV-PyMT tumors were dissected and minced, and minced pieces were
transferred to 20 ml of digestion media per tumor (DMEM, 1% fetal bovine
serum [FBS], 0.2% collagenase A (Roche), 0.2% trypsin (GIBCO 27250-
018), 50 mg/ml gentamycin, 5 mg/ml insulin) and rocked at 37C for 30–
45 min. The digested tissue was then washed twice with serum-free media
and treated with DNase for 5 min at room temperature. Tissue was resus-
pended in ice-cold serum-free media and serially centrifuged four times.
Single-cell fractions were collected and plated for 25–30 min in DMEM, 10%
FBS at 37C, 5%CO2, 20%O2. CAFs adhered to the plate, whereas other cells
did not. The supernatant and non-adherent cells were removed, and CAFs
were maintained in DMEM, 10% FBS at 37C, 5% CO2, 20% O2 for 20+
passages, splitting one to two times per week. The immortalized primary cell
lines were then submitted to fluorescence-activated cell sorting (FACS) with
PDGFRa antibodies.
ECM Production by CAFs and Fibronectin and Collagen I Staining
Human CAFs were plated to confluence on 12-mm glass coverslips in DMEM
supplemented with 10% FBS and 50 mg/ml ascorbic acid, and media were
changed daily for 7 days. Cells were extracted on day 7 (25 mmol/l Tris-HCl
[pH 7.4]; 150 mmol/l sodium chloride; 0.5% Triton X-100; and 20 mmol/l
ammonia hydroxide) for 3–5 min. Cellular debris was carefully washed away
with 13 PBS. Resultant cell-free ECMs were fixed in 4% paraformaldehyde
for 15 min at room temperature and then blocked with 5% FBS in 13 PBS.
ECMs were then incubated in mouse anti-fibronectin antibody (diluted
1:100; BD Biosciences) overnight at 4C, washed twice, and then incubated
in goat anti-mouse Alexa Fluor 488 secondary (diluted 1:500; Life Technolo-
gies), washed four times, mounted in Vectashield (VWR, 101098-044), and
sealed with nail polish. IF was analyzed on a confocal microscope (LSM
700; Carl Zeiss) at room temperature with ZEN 2009 software. ImageJ was
used to adjust brightness and contrast.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.05.033.
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